Holen Sie sich die Stockscreener-App
6.76
1.65%
0.11
Handel nachbörslich:
6.80
0.04
+0.59%
Schlusskurs vom Vortag:
$6.65
Offen:
$6.71
24-Stunden-Volumen:
167.67K
Relative Volume:
0.42
Marktkapitalisierung:
$452.19M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-11.27
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
+0.75%
1M Leistung:
-6.24%
6M Leistung:
-11.63%
1J Leistung:
-41.67%
1-Tages-Spanne:
$6.64
$6.83
1-Wochen-Bereich:
$6.465
$7.14
52-Wochen-Spanne:
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Vergleichen Sie BVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.76 | 444.83M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
134.27 | 231.52B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
SYK
Stryker Corp
|
375.29 | 141.16B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
BSX
Boston Scientific Corp
|
96.79 | 142.10B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
MDT
Medtronic Plc
|
97.87 | 126.13B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.74 | 45.04B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Is Bioventus Inc a good long term investmentSwing Trading Ideas & Rapid Capital Gain - earlytimes.in
Multi factor analysis applied to Bioventus Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - newser.com
Volatility clustering patterns for Bioventus Inc.Quarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Can Bioventus Inc. hit a new high this monthPortfolio Value Report & Technical Pattern Alert System - newser.com
How Bioventus Inc. stock benefits from strong dollarPortfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Using Bollinger Bands to evaluate Bioventus Inc.Trade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Forecasting Bioventus Inc. price range with options data2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Bioventus Inc Stock Analysis and ForecastBear Market Strategies & In-Depth Analyst Ratings Explained Simply - earlytimes.in
What drives Bioventus Inc stock priceBreakout Stock Watch & Small Investment Portfolio Growth - earlytimes.in
PetVivo (NASDAQ:PETV) versus Bioventus (NYSE:BVS) Head-To-Head Comparison - Defense World
Comparing Bioventus Inc. in custom built stock radarsProduct Launch & Fast Entry Momentum Alerts - newser.com
Comparing Bioventus (NYSE:BVS) and Retractable Technologies (NYSE:RVP) - Defense World
Orthobiologics Market May See a Big Move | Major Giants Medtronic, Zimmer Biomet, Bioventus - newstrail.com
Is Bioventus Inc. building a consolidation baseTreasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Bioventus (NYSE:BVS) Shares Gap DownHere's What Happened - MarketBeat
Bioventus Inc. stock daily chart insightsBull Run & Technical Pattern Recognition Alerts - newser.com
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating - 富途牛牛
Should You Be Worried About Bioventus Inc.'s (NASDAQ:BVS) 1.3% Return On Equity? - Yahoo Finance
Goldman Sachs Group Inc. Raises Stake in Bioventus Inc. $BVS - Defense World
Aug Closing: What is Bioventus Inc.’s TAM (Total Addressable Market)July 2025 EndofMonth & Fast Momentum Stock Entry Tips - خودرو بانک
Combining price and volume data for Bioventus Inc.Wall Street Watch & Technical Entry and Exit Alerts - newser.com
Does Bioventus Inc. show high probability of rebound2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
Aug Catalysts: Does Bioventus Inc offer margin of safetyQuarterly Growth Report & Long Hold Capital Preservation Plans - khodrobank.com
Aug Analyst Calls: What is AVPT’s TAM (Total Addressable Market)July 2025 Market Mood & Breakout Confirmation Trade Signals - khodrobank.com
Buyout Rumor: What is Bioventus Inc.’s valuation compared to sectorEarnings Trend Report & Real-Time Volume Triggers - خودرو بانک
Bioventus (NYSE:BVS) Stock Price Down 5.3%Time to Sell? - MarketBeat
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):